INFLUENCE OF UKRAIN ON IMMUNOLOGICAL BLOOD PARAMETERS IN VITRO AND IN VIVO
NOWICKY J.W.1, HIESMAYR W.1, LIEPINS A.2*
1) Ukrainian Anti-Cancer Institute, Margaretenstrasse 7,
1040 Vienna, Austria.
2) Faculty of Medicine, Memorial University, St. John's, Newfoundland, A1B 3V6, Canada.
* Author to whom correspondence should be addressed.
** Austrian Patent no. 354644
Summary: Immunological changes are often seen in subjects suffering from oncological disease. Decreased NK activity, alterations of the T4/T8 quotient, decreased phagocytic activity, low reactivity and decreased recognition of the "foreign" are common features seen in these patients. Cytostatic therapy (chemotherapy and radiation therapy) very often enhance these negative properties, thus limiting therapeutic possibilities by highly toxic sequels. Ukrain, being cytostatic and immune-stimulating and -modulating, has no adverse effects on the organism.